News
Abstracts will be made available on the ESMO website on 13 October 2025 at 00.05 CET. The posters will be available on the Posters & Publications section of Immutep’s website after their presentations ...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising ...
7d
TipRanks on MSNIdeaya Biosciences, Hengrui announce oral presentation at IASLC 2025Ideaya Biosciences (IDYA) and Jiangsu Hengrui Pharmaceuticals Co. announced the publication of an abstract for an oral presentation on IDE849 at ...
Intradural spinal arachnoid cysts versus spinal arachnoid webs: a retrospective analysis of incidence, imaging findings and clinical presentation at a single institution ...
Clinicians should be aware of this unusual presentation to facilitate timely diagnosis and appropriate management, particularly in at-risk populations. Keywords: Rickets, Vitamin D, Hypocalcemia, ...
Abstract Title: First-in-Class Oral Dual GLP-1/Glucagon Agonist for Patients with Obesity and Metabolic Disorders: In Vivo Pharmacokinetic and Pharmacodynamic Results Presentation Number: SUN-680 ...
Submission of Abstracts Abstracts (approximately 150 to 200 words on one A4 page, may contain any charts, graphs, figures and references) should give enough information on the content of the proposed ...
BOSTON – McKinsey & Company’s consultants are increasingly drafting proposals and making PowerPoint slides using the firm’s generative artificial intelligence (AI) platform, which has ...
SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T ...
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month and 24-month data from patients prior to open-label ...
TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results